» Articles » PMID: 27761375

The Role of Tumour-associated Macrophages in Bone Metastasis

Overview
Journal J Bone Oncol
Publisher Elsevier
Date 2016 Oct 21
PMID 27761375
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

This overview addresses the recent research developments in the role of tumour-associated macrophages (TAM) in bone metastasis biology and management of breast and prostate cancer as well as in primary and lung metastatic osteosarcoma. Immunosuppressive M2-type TAMs have been shown to associate with poor prognosis. Throughout their life cycle, macrophages (Macs) can adapt to environmental cues and influence the surroundings by secreting different cytokines and enzymes crucial to matrix remodelling, infection fighting, immune regulation and/or inflammation. In general terms, there is a broad and complex spectrum of Mac polarization statuses from M1 (classically activated/inflammatory) to M2 (alternatively activated/wound healing/immune regulating) Macs. Often the activation status of TAMs resembles more the M2-type. Considering the physiological functions of M2 Macs, it is no surprise that TAMs appear to have a role in metastasis, participating in almost every step of the metastatic cascade, which we review and explore in selected bone tropic cancers.

Citing Articles

Immunotherapy in the Battle Against Bone Metastases: Mechanisms and Emerging Treatments.

Hamza F, Mohammad K Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770433 PMC: 11679356. DOI: 10.3390/ph17121591.


Osteoimmunology in bone malignancies: a symphony with evil.

Song C, Tong T, Dai B, Zhu Y, Chen E, Zhang M J Natl Cancer Cent. 2024; 4(4):354-368.

PMID: 39735445 PMC: 11674455. DOI: 10.1016/j.jncc.2024.09.001.


Bone mineral density affects tumor growth by shaping microenvironmental heterogeneity.

Whitman M, Mantri M, Spanos E, Estroff L, De Vlaminck I, Fischbach C Biomaterials. 2024; 315:122916.

PMID: 39490060 PMC: 11658005. DOI: 10.1016/j.biomaterials.2024.122916.


Prostate Cancer: A Review of Genetics, Current Biomarkers and Personalised Treatments.

Wilson T, Zishiri O Cancer Rep (Hoboken). 2024; 7(10):e70016.

PMID: 39410867 PMC: 11480670. DOI: 10.1002/cnr2.70016.


Actin like 6A is a prognostic biomarker and associated with immune cell infiltration in cancers.

He Y, Li G, Wu Y, Cai N, Chen Z, Mei B Discov Oncol. 2024; 15(1):503.

PMID: 39333441 PMC: 11436596. DOI: 10.1007/s12672-024-01388-0.


References
1.
Sousa S, Brion R, Lintunen M, Kronqvist P, Sandholm J, Monkkonen J . Human breast cancer cells educate macrophages toward the M2 activation status. Breast Cancer Res. 2015; 17:101. PMC: 4531540. DOI: 10.1186/s13058-015-0621-0. View

2.
Cox T, Rumney R, Schoof E, Perryman L, Hoye A, Agrawal A . The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature. 2015; 522(7554):106-110. PMC: 4961239. DOI: 10.1038/nature14492. View

3.
Kaplan R, Rafii S, Lyden D . Preparing the "soil": the premetastatic niche. Cancer Res. 2006; 66(23):11089-93. PMC: 2952469. DOI: 10.1158/0008-5472.CAN-06-2407. View

4.
Ok Atilgan A, Ozdemir B, Yilmaz Akcay E, Ataol Demirkan O, Agah Tekindal M, Ozkardes H . Role of tumor-associated macrophages in the Hexim1 and TGFβ/SMAD pathway, and their influence on progression of prostatic adenocarcinoma. Pathol Res Pract. 2015; 212(2):83-92. DOI: 10.1016/j.prp.2015.10.011. View

5.
Soki F, Cho S, Kim Y, Jones J, Park S, Koh A . Bone marrow macrophages support prostate cancer growth in bone. Oncotarget. 2015; 6(34):35782-96. PMC: 4742141. DOI: 10.18632/oncotarget.6042. View